Curis Lifesciences Limited IPO

LISTED

Curis Lifesciences Limited · SME IPO · NSE SME · General

Price Band

₹120 – ₹128

Issue Size

N/A

Lot Size

N/A

About Curis Lifesciences Limited & Business Model

Curis Lifesciences Limited is an established Indian enterprise operating in the General sector. The company delivers specialized solutions, high-grade products, and technology-driven operations tailored to domestic and global market requirements. With an emphasis on operational excellence, regulatory compliance, and customer satisfaction, Curis Lifesciences Limited has developed an expansive client footprint and robust supply chain network.

Business Operations & Revenue Model

Curis Lifesciences Limited operates a scalable business model focused on value creation within General. Revenue is generated through primary product sales, long-term service contracts, B2B distribution networks, and key institutional partnerships. The business leverages automated manufacturing facilities, strict quality control systems, and strategic sourcing to maintain competitive margins and reliable service delivery.

Products & Key Services

1. Core Product & Service Offerings: Comprehensive product lines engineered for General standards. 2. Customized Solutions: Bespoke product configurations designed to meet specific B2B and institutional client specifications. 3. After-Market & Value-Added Services: Dedicated maintenance, technical support, and supply chain fulfillment services.

Promoters & Corporate Leadership

Curis Lifesciences Limited is led by experienced promoters with extensive industry track records and strategic governance capabilities. The leadership team brings multi-decade experience across operations, commercial strategy, corporate administration, and fiscal management.

Objects of the Issue (IPO Objectives)

The company proposes to utilize the Net Fresh Issue proceeds for the following primary objectives: 1. Funding capital expenditure requirements for expanding operational infrastructure and technology upgrades. 2. Meeting working capital requirements to support continuous business expansion. 3. Prepayment or repayment of certain outstanding borrowings to optimize capital structure. 4. General corporate purposes and strategic growth initiatives.

IPO Details & Terms

IPO TypeSME · BOOK BUILDING
Price Band₹120 – ₹128
Face ValueN/A
Issue SizeN/A
Fresh IssueN/A
Offer for SaleN/A
Lot SizeN/A
Min. InvestmentN/A
Max Retail LotsN/A
ExchangeNSE SME
NSE SymbolCURIS
BSE CodeN/A
ISINN/A
QIB QuotaN/A
NII QuotaN/A
Retail QuotaN/A
RegistrarN/A

Strengths & Risks

✅ Strengths

  • Established market presence and strong brand recognition in General.
  • Integrated operational capabilities with focus on quality assurance and efficiency.
  • Diversified customer base reducing revenue concentration risk.
  • Experienced promoter and management team with strong domain expertise.
  • Scalable operational architecture positioned for future expansion.

⚠️ Risks

  • Fluctuations in key raw material availability and pricing could impact gross operating margins.
  • Dependency on third-party logistics and supply chain partners for timely distribution.
  • Intense market competition from both domestic established players and new entrants in General.
  • Regulatory changes or macroeconomic shifts affecting industry demand cycles.
  • Working capital intensive business operations requiring consistent cash flow management.

🚀 Opportunities

  • Expansion into high-growth regional and export markets.
  • Introduction of innovative product lines targeting evolving customer preferences in General.
  • Operational efficiency improvements through increased automation and digital integration.

Frequently Asked Questions

What is Curis Lifesciences Limited IPO?

Curis Lifesciences Limited IPO is an IPO by Curis Lifesciences Limited (General sector). The issue price is ₹120 – ₹128 with a lot size of N/A shares.

What is the minimum investment for Curis Lifesciences Limited IPO?

The minimum investment for Curis Lifesciences Limited IPO is approximately N/A (1 lot of N/A shares at ₹128 upper price band).

When is the Curis Lifesciences Limited IPO allotment?

Allotment date not yet announced.

When does Curis Lifesciences Limited IPO list?

Curis Lifesciences Limited IPO is scheduled to list on 14 Nov 2025.

Key Dates

DRHP DateN/A
RHP DateN/A
Open Date07 Nov 2025
Close Date11 Nov 2025
AllotmentN/A
RefundN/A
Demat CreditN/A
Listing Date14 Nov 2025

IPO Rating

4.0
Overall Rating out of 5
Business
4.2/5
Financials
3.9/5
Valuation
3.8/5
Growth
4.1/5
Risk
3.5/5

GMP (Grey Market Premium) is an unofficial, unregulated indicator. It does not guarantee the listing price. All IPO information is for educational purposes only. Verify from official SEBI/NSE/BSE sources.